_{231. Sauberlich HE: Implications of nutritional status on human biochemistry, physiology and health. Clin Biochem 17:132–142, 1984.}

_{232. Scarlett JD, Read H, et al.: Protein-bound cobalamin absorption declines in the elderly. Am J Hematol 39:79–83, 1992.}

_{233. Schaumberg H, Kaplan J, et al.: Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome. N Engl J Med 309:445–448, 1983.}

_{234. Schmid A, Jakob E, et al.: Effect of physical exercise and vitamin С on absorption of ferric sodium citrate. Med Sci Sports Exerc 28:1470–1473, 1966.}

_{235. Schneider HA, Anderson CE, Coursin DB: Nutritional Support of Medical Practice. Harper & Row, Hagerstown, Md., 1977 (pp. 37, 38, III, 115–118, 131, 436, 450, 480–482).}

_{236. Shackleton PJ, Fish DI, et al.: Intrinsic factor antibody tests. J Clin Pathol 42:210-212, 1989.}

_{237. Shane B: Vitamin B6 and blood. Chapter 7. In: Human Vitamin B6 Requirements. National Academy of Sciences, Washington, 1978 (pp. 115, 122–124).}

_{238. Sharav Y, Tzukert A, Refaeli B: Muscle pain index in relation to pain, dysfunction, and dizziness associated with the myofascial pain-dysfunction syndrome. Oral Surg 46:742–747, 1978.}

_{239. Shaw S, Lieber CS: Nutrition and alcoholism. Chapter 40. In: Modem Nutrition in Health and Disease. Ed. 6. Edited by Goodhart RS, Shils ME. Lea & Febiger, Philadelphia, 1980 (pp. 1225, 1226).}

_{240. Ibid. (p. 1235).}

_{241. Shevell Ml Rosenblatt DS: The neurology of cobalamin. Can J Neurol Sci 19:472–486, 1992.}

_{242. Shils ME: Magnesium. Chapter 7B. In: Modem Nutrition in Health and Disease. Ed.6. Edited by Goodhart RS, Shils ME. Lea & Febiger, Philadelphia, 1980 (pp. 315, 317).}

_{243. Shils ME: Nutrition and neoplasia. Chapter 38. In: Modem Nutrition in Health and Disease. Ed. 6. Edited by Goodhart RS, Shils ME. Lea & Febiger, Philadelphia, 1980 (pp. 1179, 1180).}

_{244. Shorvon SD, Reynolds EH: Folate deficiency and peripheral neuropathy. Chapter 37. In: Folic Acid in Neurology, Psychiatry, and Internal Medicine. Edited by Botez MI, Reynolds EH. Raven Press, New York, 1979 (p. 420).}

_{245. Shorvon SD, Cammey MW, et al.: The neuropsychiatry of megaloblastic anemia. Br Med J 281:1036–1038, 1980.}

_{246. Sicuranza BJ, Richards J, Tisdall LH: The short leg syndrome in obstetrics and gynecology. Am J Obstet Gynecol 107:217–219, 1970.}

_{247. Simons DG, Travell J: Common myofascial origins of low back pain. Postgrad Med 73:66—108, 1983.}

_{248. Singer PA, Cooper DS, et al.: Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 273:808–812, 1995.}

_{249. Smith JL, Hodges RE: Serum levels of vitamin С in relation to dietary and supplemental intake of vitamin С in smokers and nonsmokers. Ann NY Acad Sci 498:144–152, 1987.}

_{250. Smythe HA: Fibrositis and other diffuse musculoskeletal syndromes. In: Textbook of Rheumatology, Vol I. Edited by Kelley WN, Harris ED Jr, Ruddy S, et al. W. B. Saunders, Philadelphia, 1981 (p. 489).}

_{251. Solanki DL, Jacobson RJ, et al.: Pernicious anemia in blacks: a study of 64 patients from Washington, DC, and Johannesburg, South Africa. Am J Clin Pathol 75:96–99, 1981.}

_{252. Sonkin LS: Myofascial pain due to metabolic disorders: diagnosis and treatment. Chapter 3. In: Myofascial Pain and Fibromyalgia. Edited by Rachlin ES. Mosby, St. Louis, 1994 (pp. 45–60).}

_{253. Staub JJ, Althaus BU, et al.: Spectrum of subclinical and overt hypothyroidism. Am J Med 92:631–641, 1992.}

_{254. Stead WW: Tuberculosis. Chapter 156. In: Harrison’s Principles of Internal Medicine. Ed. 7. Edited by Wintrobe MM, Thorn GW, Adams RD, et al. McGraw-Hill, New York, 1974 (p. 867).}

_{255. Sterling K: Thyroid hormone action at the cell level. N Engl J Med 300:117–123, 173–177, 1979.}

_{256. Stembach RA: Pain Patients, Traits and Treatment, Academic Press, New York, 1974 (pp. 40–51).}

_{257. Stembach DJ: Stress in the lives of musicians — on stage and off. In: Bejjani FJ, Current Research in Arts Medicine. Chicago: A Capella Books, 1993.}

_{258. Surks MI, DeFesi CR: Normal serum free thyroid hormone concentrations in patients treated with phenytoin or caibamazepine. JAMA 275:1495–1498. 1966.}

_{259. Surks MI, Sievert R: Drugs and thyroid function. N Engl J Med 333:1688–1694, 1995.}

_{260. Swanson JW, Kelly JJ, et al.: Neurologic aspects of thyroid dysfunction. Mayo Clin Proc 56:504–512, 1981.}

_{261. Tallaksen CM, Bohmer T, et al.: Concentrations of the water-soluble vitamins thiamin, ascoibic acid, and folic acid in serum and cerebrospinal fluid of healthy individuals. Am J Clin Nutr 56:559–564, 1992.}

_{262. Taylor TV, Rimmer S, Day B, et al.: Ascorbic acid supplementation in the treatment of pressure-sores. Lancet 2:544–546, 1974.}

_{263. Tefferi A, Pruthi RK: The biochemical basis of cobalamin deficiency. Mayo Clin Proc 69:181–186, 1994.}

_{264. Theuer RC, Vitale JJ; Drug and nutrient interactions. Chapter 18. In: Nutritional Support of Medical Practice. Edited by Schneider HA, Anderson CE, Coursin DB. Harper & Row, 1977 (pp. 299, 300, 302).}

_{265. Thomson AD, Baker H, Leevy CM. Patterns of ³⁵S-thiamine hydrochloride adsorption in the malnourished alcoholic patient. J Lab Clin Med 76:34–45, 1970.}

_{266. Thornton WE, Thornton BP: Folic acid, mental function, and dietary habits. J Clin Psychiatry 39:315–319, 322, 1978.}

_{267. Thurnham Dl: Red cell enzyme tests of vitamin status: do marginal deficiencies have physiological significance? Proc Nutr Soc 40:155–163, 1981.}

_{268. Tichauer ER: Industrial engineering in the rehabilitation of the handicapped. J lndustr Eng 19:96—104, 1968.}

_{269. Timmerman MG: Medical problems of adolescent female athletes. Wis Med J 95:351–354, 1996.}

_{270. Toft AD: Thyroxine therapy. N Engl J Med 1994 331:174–180, 1994.}

_{271. Tomkin GH, Hadden DR, Weaver JA, et al.: Vitamin B, status of patients on longterm metformin therapy. Br Med J 2:685–687, 1971.}

_{272. Travell J: Referred pain from skeletal muscle: the pectoralis major syndrome of breast pain and soreness and the sternomastoid syndrome of headache and dizziness. NY State J Med 55:331–339, 1955.}

_{273. Travell J: Office Hours: Day and Night. The World Publishing Company, New York, 1968.}

_{274. Travell J: Low back pain and the Dudley J. Morton foot (long second toe). Arch Phys Med Rehabil 56:566, 1975.}

_{275. Travell J: Identification of myofascial trigger point syndromes: a case of atypical facial neuralgia. Arch Phys Med Rehabil 62:100-106, 1981.}

_{276. Travell J, Rinzler SH: The myofascial genesis of pain. Postgrad Med 11:425–434, 1952.}

_{277. Travell JG: The quadratus lumborum muscle: an overlooked cause of low back pain. Arch Phys Med Rehabil 57:566, 1976.}

_{278. Uchida T: Overview of iron metabolism. Int J Hematol 62:193–202, 1995.}

_{279. Utiger RD: Therapy of hypothyroidism. N Engl J Med 323:126–127, 1990.}

_{280. Vallance S: Relationships between ascorbic acid and serum proteins of the immune system. Br Med J 2:437–438, 1977.}

_{281. van der Metz J. Westhuyzen J: The fruit bat as an experimental model of the neuropathy of cobalamin deficiency. Comp Biochem Physiol 171–177, 1987.}

_{282. Van Itallie ТВ: Assessment of nutritional status. Chapter 75. In: Harrison’s Principles of Internal Medicine. Ed. 7. Edited by Wintrobe MM, Thome GW, Adams RD, et al. McGraw-Hill, New York, 1974 (p. 419).}